This sub-$10 pharma stock is attempting a bullish breakout, according to the charts
CNBC: Investing
JULY 2, 2025
A few months later in early 2009, the stock went on to break through a steep downtrend line that had been in place for two years. THIS CONTENT IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSITUTE FINANCIAL, INVESTMENT, TAX OR LEGAL ADVICE OR A RECOMMENDATION TO BUY ANY SECURITY OR OTHER FINANCIAL ASSET.
Let's personalize your content